“The clinical trial results are one of the two major catalysts that affect the stock price of a biotech company, and more so if it is a small/mid-cap stock,” notes the author of today’s article. They proceed to highlight five specific biotech stocks with “near-term milestones” to watch in the coming weeks. For these five stocks, CLICK HERE.